Episode 322: Rich Ferrari, Co-Founder, De Novo Ventures (replay)

This week, we revisit our conversation with Rich Ferrari. Rich is a seasoned healthcare entrepreneur and investor with a track record of building and scaling medical device and biotech companies. He is a Co-Founder of De Novo Ventures, a premier life sciences venture firm that managed $650M, and has helped raise over $1B in capital while contributing to nearly $1.8B in successful acquisitions. Most recently, Rich served as CEO and Chairman of PQ Bypass, leading to its $350M acquisition by Endologix. He has also led and exited multiple companies, including Cardiovascular Imaging Systems (acquired by Boston Scientific) and CardioThoracic Systems (acquired by Guidant), where he drove one of the fastest IPOs in medtech history. A prolific founder, Rich has co-founded several successful ventures acquired by major players like Johnson & Johnson, Abbott, and Medtronic. He currently serves on multiple boards, including Tenon Medical (NASDAQ: TNON), HeartBeam, and Medlumics. Rich holds a BS from Ashland University and an MBA from the University of South Florida, and is a recipient of the Mallinckrodt Award for Excellence in Medicine.